Liminatus Pharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Liminatus Pharma Inc.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
/ 
Frequently asked questions
To buy Liminatus Pharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Liminatus Pharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Liminatus Pharma Inc. is LIMN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Liminatus Pharma Inc. has its primary listing on NASDAQ. You can trade Liminatus Pharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Liminatus Pharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Liminatus Pharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Liminatus Pharma Inc..